| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Thomas J. Salentine Jr. | Director | 2026-03-20 | 3,570,677 | $29.68 | $105.99MSell |
| John Ackerman | Director | 2026-03-20 | 275,728 | $29.68 | $8.18MSell |
| Bindley Capital Partners I LLC | 10% Owner | 2026-03-20 | 3,570,677 | $29.68 | $105.99MSell |
| William E. Bindley | Director | 2026-03-20 | 3,570,677 | $29.68 | $105.99MSell |
| Fred Burke | President and Chief Executive Officer | 2026-03-20 | 671,432 | $29.68 | $19.93MSell |
| Cardinal Equity Fund LP | Insider | 2026-03-20 | 275,728 | $29.68 | $8.18MSell |
| John Ackerman | Director | 2026-03-20 | 827,636 | $29.68 | $24.57MSell |
| Kendall Forbes | Executive Vice President Sales Operations | 2026-03-20 | 346,672 | $29.68 | $10.29MSell |
| David K. Morris | Executive Vice President and Chief Financial Officer | 2026-03-20 | 187,855 | $29.68 | $5.58MSell |
| Pharmacy Investors LLC | Insider | 2026-03-20 | 827,636 | $29.68 | $24.57MSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Thomas J. Salentine Jr. | 16.74% | 10,605,205 | $462.81M | Insider |
| Bindley Capital Partners I LLC | 16.69% | 10,569,491 | $461.25M | Insider |
| William E. Bindley | 16.69% | 10,569,491 | $461.25M | Insider |
| John Ackerman | 5.16% | 3,266,047 | $142.53M | Insider |
| Pharmacy Investors LLC | 3.87% | 2,449,867 | $106.91M | Insider |
| Fred Burke | 3.38% | 2,139,239 | $93.36M | Insider |
| Kendall Forbes | 1.68% | 1,061,826 | $46.34M | Insider |
| David K. Morris | 1.42% | 896,341 | $39.12M | Insider |
| Cardinal Equity Fund LP | 1.29% | 816,180 | $35.62M | Insider |
| Jeffrey Tuch | 0.28% | 176,269 | $7.69M | Insider |